tenk.fyi

VOLITIONRX LTD

VNRXNYSE· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$1.7M

40.0% YoY

Net Income

-$23.4M

13.4% YoY

EPS

-

Cash

$1.1M

65.8% YoY

FY 2025 · As of 2025-12-31